David McClung - 31 May 2023 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Reporting relationship: Chief Financial Officer
Issuer ticker: BCDA
Reported as of: 31 May 2023
Net transaction value: -$36,597
SEC form: 4
Accepted by SEC: 02 Jun 2023, 18:24:02 UTC
Prior SEC filing: 22 May 2023
Next SEC filing: 26 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ David McClung

Key filing fact

David McClung filed Form 4 for BioCardia, Inc. (BCDA) on 02 Jun 2023.

Key facts

This page summarizes David McClung's Form 4 filing for BioCardia, Inc. (BCDA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jun 2023, 18:24.

Change

Previous filing in this sequence was filed on 22 May 2023.
Current net transaction value: -$36,597.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCDA transaction

Common Stock

Tax liability

Transaction value: $36,597
Shares: -20,676
Change %: -14%
Price: $1.77
Shares after: 131,444
Date: 31 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on May 18, 2023 and does not represent a sale by the Reporting Person.